Kardigan, Inc. (KARD)
15.71
+0.19
(+1.22%)
USD |
NASDAQ |
Nov 09, 12:28
Kardigan Enterprise Value : 866.37M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 866.37M |
| November 05, 2026 | 711.22M |
| November 04, 2026 | 870.11M |
| November 03, 2026 | 754.21M |
| November 02, 2026 | 743.93M |
| October 30, 2026 | 736.45M |
| October 29, 2026 | 753.28M |
| October 28, 2026 | 699.07M |
| October 27, 2026 | 686.92M |
| October 26, 2026 | 596.25M |
| October 23, 2026 | 612.14M |
| October 22, 2026 | 606.53M |
| October 21, 2026 | 616.81M |
| October 20, 2026 | 678.50M |
| October 19, 2026 | 625.23M |
| October 16, 2026 | 633.64M |
| October 15, 2026 | 713.09M |
| October 14, 2026 | 679.44M |
| October 13, 2026 | 628.03M |
| October 12, 2026 | 757.02M |
| October 09, 2026 | 786.93M |
| October 08, 2026 | 743.00M |
| October 07, 2026 | 708.41M |
| October 06, 2026 | 676.63M |
| October 05, 2026 | 840.20M |
| Date | Value |
|---|---|
| October 02, 2026 | 798.14M |
| October 01, 2026 | 747.67M |
| September 30, 2026 | 794.40M |
| September 29, 2026 | 785.99M |
| September 28, 2026 | 797.21M |
| September 25, 2026 | 798.14M |
| September 24, 2026 | 760.76M |
| September 23, 2026 | 772.91M |
| September 22, 2026 | 952.36M |
| September 21, 2026 | 939.28M |
| September 18, 2026 | 971.06M |
| September 17, 2026 | 975.73M |
| September 16, 2026 | 1.034B |
| September 15, 2026 | 1.151B |
| September 14, 2026 | 1.196B |
| September 11, 2026 | 1.147B |
| September 10, 2026 | 1.163B |
| September 09, 2026 | 1.255B |
| September 08, 2026 | 1.435B |
| September 04, 2026 | 1.365B |
| September 03, 2026 | 1.354B |
| September 02, 2026 | 1.465B |
| September 01, 2026 | 1.248B |
| August 31, 2026 | 1.300B |
| August 28, 2026 | 1.287B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.715B |
| Corcept Therapeutics, Inc. | 7.597B |
| Veru, Inc. | 13.04M |
| Johnson & Johnson | 692.32B |
| Eli Lilly & Co. | 1.319T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -116.24M |
| Total Expenses (Quarterly) | 116.24M |
| EPS Diluted (Quarterly) | -1.244 |
| Earnings Yield | -17.29% |
| Normalized Earnings Yield | -15.02 |